Posted on

Lost money at your ADMA Biologics, Inc.

Lost money at your ADMA Biologics, Inc.

NEW YORK, Oct. 17, 2024 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ: ADMA) for possible violations of the federal securities laws.

If you have invested in ADMA Biologics, we recommend you visit for more information .

Why did ADMA Biologics stock fall?

ADMA Biologics is a commercial biopharmaceutical company that manufactures, markets and develops specialty biologics for the treatment of immunocompromised patients at risk of infection and others at risk for certain infectious diseases.

On October 9, 2024, ADMA Biologics announced the surprise resignation of its independent external auditor, CohnReznick LLP.

The news caused ADMA Biologics shares to fall sharply. During trading on October 10, 2024, ADMA Biologics stock price fell more than 20%.

Click here for more information: .

What can you do?

If you have invested in ADMA Biologics, you may have legal options and may be required to provide your information to the company. All representations are made on a contingency fee basis and there are no costs to you. The shareholders are not responsible for any court costs or litigation costs. The Company will seek court approval for any fees and expenses.

Submit your information by visiting:

Or contact:
Ross Shikowitz
[email protected]
212-789-3619

Why Bleichmar Fonti & Auld LLP?

Bleichmar Fonti & Auld LLP is a leading international law firm representing plaintiffs in securities class actions and shareholder lawsuits. It was named one of the top five plaintiff law firms by ISS SCAS in 2023 and its attorneys were named Titans of the Plaintiffs’ Bar by Law360 and SuperLawyers by Thompson Reuters. Recent notable successes include BFA being valued at over $900 million by the board of Tesla, Inc. (pending court approval) and $420 million by Teva Pharmaceutical Ind. Ltd. has requested back.

For more information about BFA and its attorneys, see

Lawyer advertising. Past results are no guarantee of future results.